Figure 3. Day 2 cell symmetry

Slides:



Advertisements
Similar presentations
Cancer cachexia by J.N. Gordon, S.R. Green, and P.M. Goggin QJM Volume 98(11): October 17, 2005 © The Author Published by Oxford University.
Advertisements

Morphological changes in the rat periodontal ligament and its vascularity after experimental tooth movement using superelastic forces by Koji Noda, Yoshiki.
Fig. 1. Flow diagram of study participants and outcomes.
From: An open day in the metric space
Figure 1 WBC count (A), platelet count (B), MPV (C), platelet activation rate (D) and TGF-β1concentration (E) in the PF of women with endometriosis and.
From: Global Banking: Recent Developments and Insights from Research*
Figure 1. Scheme and photographs of the container for vitrification using the ‘straw in straw’ mode: (1) 0.5 ml straw; (2) metal closing ball; (3) open-pulled.
The devices are shown before sample has been added
Figure 2. Quality of life (QOL) scores for functional scale items
Figure 2. CONSORT flow diagram.
Figure 1. Representative example of the pattern of oxygen consumption for assessment of mitochondrial function. The dashed line represents values from.
Figure 1 Cumulative chance of pregnancy according to age at initiation of pregnancy seeking. The curves were drawn based on the following assumptions:
Figure 3. Average response time by signal-to-noise ratio (SNR), group, and condition. Error bars represent standard error. Response time was measured as.
Figure 6 Case 6: (A) MRA showed occlusion of the left internal carotid artery. (B) MRI 4 days before cell injection and (C) 7 days after cell injection.
Figure 1. Conceptual model of well-being related to involvement in theatre. From: Theatre Involvement and Well-Being, Age Differences, and Lessons From.
Figure 1 Individual Lifted from Group Photograph
Figure 1. Orthodontic set-up and location of LLLT or placebo-laser
Figure 2. Illustration of minimum cross-sectional area (a) and measurements for oropharynx and soft palate in sagittal plane (b, c). From: Airway volume.
Figure 2. (A) Sézary syndrome patient before treatment
Figure 1 Flow chart showing the selection of publications identified in the literature search. From: GnRH antagonist versus long agonist protocols in IVF:
From: Where do we go from here
Figure 1. Activity found in nose swabs and early faecal excretion for each subject at the MOX facilities. From: Practical action levels for chelation therapy.
Example 14. Schubert, Quartet in G Major, D
Figure 2 Distribution of Annual Household Income for Jordan Overall, Camp Refugees, and Camp Poor From: A Profile of Poverty for Palestinian Refugees in.
Figure 1 Flow chart of search and selection strategy for studies in a systematic review of endometrial thickness during IUI with ovarian stimulation. *
From: Estimating the Location of World Wheat Price Discovery
Figure 1. Time of initiation of therapeutic hypothermia according to who initiated it. Note the logarithmic scaling of the vertical axis. From: Initiation.
From: Intention, Interpretation, and Contemporary Visual Art
Figure 1: Time points at which sperm samples were analysed for aneuploidy frequencies in controls and cancer patients From: Sperm aneuploidy frequencies.
Figure 1. Dosage and administration route of drugs used in the BMD study. Each cycle was proposed every 28 days (‘base’ schedule) or 35 days (‘weekly’
Figure 1. Percentage of trainees is represented on the y-axis for each competency/knowledge item represented in the x-axis. Only Poor/Fair (P/F) ratings.
Figure 1 Flowchart for the study population.
Figure 2 Comparison of pregnancy outcomes between true NC-FET and modified NC-FET. Odds ratio (OR) adjusted for clinical pregnancy (OR 0.90, 95% CI 0.73–1.12)
Figure 1 PRISMA flow diagram illustrating the process of selection of studies for inclusion in the systematic review. From: How effective are weight-loss.
Figure 1. (A) Cumulative risk of breast (diamonds) and ovarian (squares) cancer in BRCA1 mutation carriers. (B) Cumulative risk of breast (diamonds) and.
Figure 1. Impact ratings for prospective memory lapses for younger (~age 30), middle-age (~age 50), and older (~age 65) adults. From: Daily Memory Lapses.
Figure 1. Scattergram of serum CA-125 levels in 775 consecutive patients who had been diagnosed with gynecologic disease by laparotomy or laparoscopy.
Figure 1. Progression-free survival and overall survival for FL/DLBCL patients. From: Clinicobiological features and prognostic impact of diffuse large.
Figure 1. Percentage of participants in each group (holocaust survivors, prewar immigrants, and postwar immigrants) by the main coded strategies. From:
Figure 7 miRNA and mRNA gene expression changes in the Poor Group
FIG. 4. Working lifetime combined risk from fatal heart disease and lung cancer based on Hong Kong exposure to secondhand tobacco smoke and both US and.
Figure 1. The cell-lineage specification of the early mouse embryo
Fig. 5 Detailed classifier results for tweets (a) J48, (b) SVM, and (c) NB From: A sentiment analysis system for social media using machine learning techniques:
توزیع جغرافیایی مرگ به دلیل بدخیمی در کشور Age-standardized incidence rate of all cancers per 100 000 in female in Iran 2005–2006.
Transfer of blastocysts with deviant morphological and morphokinetic parameters at early stages of in-vitro development: a case series  Astrid Stecher,
Morphological embryo assessment: reevaluation
Figure 1. HR (95% CI) of death from dementia associated with weight or BMI in middle age and in old age. From: Adiposity in middle and old age and risk.
Figure 4. Influence of Clerk Ideology on Justice Voting.
Outcome of cryotransfer of embryos developed from vitrified oocytes: double vitrification has no impact on delivery rates  Ana Cobo, Ph.D., Damià Castellò,
Figure 1 Flow diagram detailing the systematic review process.
Figure 1 Mechanism of mortality benefit associated with radial access
Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.
Figure 1 Sources of uncertainty introduced in each stage of the standard modelling approach for estimating ... Figure 1 Sources of uncertainty introduced.
Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.
Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.
Take home figure The protective role of CNP/NPR-B/NPRC.
Fig. 1 Flow chart of included patients for analyses
Fig. 1 Flow chart for selection of study subjects
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Figure 1 Immunohistochemistry for human cell differentiation molecules in samples of the right ventricular septum from ... Figure 1 Immunohistochemistry.
Figure 1. Percentage of Pacific and European children completing all components of B4SC in 2013 and 2015 Figure 1. Percentage of Pacific and European.
Figure 1. Trunk and leg fat over study period. LS, log transformed.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Figure 1. Oncoprint of selected pathogenic alterations detected in ctDNA. Unless provided in the caption above, the following copyright applies to the.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Figure 1 Grant agencies and charitable foundations supporting Plan S.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Figure 1 ABCDE of primary prevention.2
Figure 1. Forest plot of lung cancer mortality in LDCT trials.
Presentation transcript:

Figure 3. Day 2 cell symmetry Figure 3. Day 2 cell symmetry. The percentage of even or uneven blastomeres from 1076 day 2 embryos depending on their fate: series 1. From: Morphologic parameters of early cleavage-stage embryos that correlate with fetal development and delivery: prospective and applied data for increased pregnancy rates Hum Reprod. 2006;22(1):230-240. doi:10.1093/humrep/del358 Hum Reprod | © The Author 2006. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Figure 4. Day 2 cell number. The percentage of each cell stage for 1076 day 2 embryos depending on their fate: series 1. From: Morphologic parameters of early cleavage-stage embryos that correlate with fetal development and delivery: prospective and applied data for increased pregnancy rates Hum Reprod. 2006;22(1):230-240. doi:10.1093/humrep/del358 Hum Reprod | © The Author 2006. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Figure 1. Pronuclear (PN) score Figure 1. Pronuclear (PN) score. The percentage of each PN score for 1193 fertilized oocytes depending on their fate: series 1. From: Morphologic parameters of early cleavage-stage embryos that correlate with fetal development and delivery: prospective and applied data for increased pregnancy rates Hum Reprod. 2006;22(1):230-240. doi:10.1093/humrep/del358 Hum Reprod | © The Author 2006. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Figure 2. Day 2 state of nucleation Figure 2. Day 2 state of nucleation. The percentage of each nucleation score for 1076 day 2 embryos depending on their fate: series 1. 1n/b, 1 nucleus per blastomere; nnv, nuclei not visible and MN, multinucleation. From: Morphologic parameters of early cleavage-stage embryos that correlate with fetal development and delivery: prospective and applied data for increased pregnancy rates Hum Reprod. 2006;22(1):230-240. doi:10.1093/humrep/del358 Hum Reprod | © The Author 2006. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org